Proteins

Items 861-870 of 936

per page
Set Descending Direction
  1. TNF Ligands Enhancer
    AG-35B-0001
    AG-35B-0001-C05050 µg
    CHF 310.00
  2. TNF-α (human) (multimeric) (rec.)
    AG-40B-0019
    AG-40B-0019-C01010 µg
    CHF 215.00
    AG-40B-0019-30103 x 10 µg
    CHF 430.00
  3. TNF-α (mouse) (multimeric) (rec.)
    AG-40B-0021
    AG-40B-0021-C01010 µg
    CHF 215.00
    AG-40B-0021-30103 x 10 µg
    CHF 430.00
  4. TNF-α, Soluble (human) (rec.)
    AG-40B-0006
    AG-40B-0006-C01010 µg
    CHF 95.00
    AG-40B-0006-C05050 µg
    CHF 215.00
    AG-40B-0006-30503 x 50 µg
    CHF 430.00
    TNF-α, Soluble (human) (rec.)(AG-40B-0074) induces NF-κB dependent genes. Methods: Endothelial cells (HUVEC) are incubated for 1h in the presence of BAY 11-7082 (AG-CR1-0013) and then treated with TNFα (20ng/ml) (red bar) or incub
  5. TNF-R1 (human):Fc (human) (rec.)
    AG-40B-0074
    AG-40B-0074-C05050 µg
    CHF 215.00
    AG-40B-0074-30503 x 50 µg
    CHF 430.00
    Inhibition of TNFα-induced genes by TNF-R1 (human):Fc (human) (rec.) (AG-40B-0074). Methods: Endothelial cells (HUVEC) are incubated for 1h in the presence of BAY 11-7082 (AG-CR1-0013) and then treated with TNFα (AG-40B-0006) (20ng/ml)
  6. TRAIL, Soluble (human) (rec.)
    AG-40B-0003
    AG-40B-0003-C01010 µg
    CHF 85.00
    AG-40B-0003-50105 x 10 µg
    CHF 250.00
  7. TRAIL-R1 (human):Fc (human) (rec.)
    AG-40B-0070
    AG-40B-0070-C05050 µg
    CHF 215.00
    AG-40B-0070-30503 x 50 µg
    CHF 430.00
  8. TRAIL-R2 (human):Fc (human) (rec.)
    AG-40B-0071
    AG-40B-0071-C05050 µg
    CHF 215.00
    AG-40B-0071-30503 x 50 µg
    CHF 430.00
  9. TREX1 (human) (rec.) (His) (active) (100µg)
    BBL-2265
    BBL-2265-C100100 µg
    CHF 4'559.00
    TREX1 (human) (rec.) (His) (active) (100µg)
  10. TREX1 (human) (rec.) (His) (active) (10µg)
    BBL-2262
    BBL-2262-C01010 µg
    CHF 1'227.00
    TREX1 (human) (rec.) (His) (active) (10µg)

Items 861-870 of 936

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.